Sufi Sufian

- Spearheaded the conceptualization and proposal of the company's first Patient Access Program (PAP), named "Hope for Health", to enhance patient support and improve treatment adherence. - Successfully advocated for the creation of a dedicated PAP Team, aligning executive leadership with a new strategic vision for patient-centric engagement.

- Provided strategic counsel to the CEO on integrating patient access initiatives with core commercial, medical, and regulatory functions to optimize patient outcomes and gather real-world data.

Advised CEO on long-range strategic planning, optimizing the portfolio to increase market share by 15%. Restructured commercial models to enhance customer centricity, improving response time by 20%.

Analyzed the whole Oral Anti Diabetic Medicines and prepared a full go-to-market business plan

Developed frameworks to navigate generic/biosimilar competition, securing 50% revenue growth in core therapeutic areas.

Partnered with Iranian gov. bodies (IFDA, Parliament, MOH) to deploy nationwide omnichannel solutions and telehealth services. Leveraged big data analytics to optimize the pharma value chain, reduce marketing expenses, and provide data-driven solutions for pharmaceuticals. Supported NGOs (e.g., Iranian Thalassemia Society) with med distribution analytics to manage patient OOP effectively. Improved diagnosis quality and prescription accuracy by managing a high volume of stakeholder calls (~ 1,000/m).

Streamlined communications: government bodies, medical uni.s, and patient societies, accelerating patient access to affordable medicine across 16 centers (covering >80% of Thalassemia patients). Implemented capacity-building models: ensure medicine access over 95% of Thal. patients and affordability for over 70%. Secured reimbursement of Everolimus for transplant by supervising a new pharmacoeconomics study, leading stakeholder engagement, and reducing patient OOP.

- Delivered the tasks that were assigned by the Ethics, Risks, and Compliance Head: - Obtained 10 third parties’ confidential information and prepared due diligence drafting in the local office to be dispatched to global teams quickly and smoothly. 100% of the company’s third parties are fully vigilant of the SOPs of the country and organization.

Built transparent and strong liaisons with around 130 physicians, and 100 pharmacists nationwide, which led to a significant increase in their medical knowledge, and as a result, a diabetic patient could benefit from quality treatment.

Performed a Medical Representative's tasks as a senior.

Entry Level Medical Representative